360 NEWS360 NEWS

360° Perspective · National

Research Explores Anlotinib’s Role in Reducing Fibroblast Activation During Pulmonary Fibrosis

Idiopathic pulmonary fibrosis remains a challenging progressive lung condition with few effective treatments available today. A recent investigation examined how the medication anlotinib might influence fibroblast behavior in this disease through a particular molecular route involving integrin beta...

Verified Timeline

No verified timeline updates.

Voluntary Reader Opinion

What is your view on “Research Explores Anlotinib’s Role in Reducing Fibroblast Activation During Pulmonary Fibrosis”?

This is self-selected reader participation, not representative scientific polling.